ArticleBMC cancer2026
Regulatory mechanisms and functional analysis of cellular senescence-associated genes GAPDH, CCND1, and HBEGF in the immune microenvironment of meningioma.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeningioma is a common tumor of the central nervous system, yet its pathogenesis remains incompletely understood. Cellular senescence and associated genes play crucial roles in the development of various tumors; however, their functional roles and interactions with the immune microenvironment in meningioma remain poorly characterized.
objectiveThis study aims to systematically elucidate the roles of cellular senescence-related genes in meningioma pathogenesis and the tumor immune microenvironment by integrating transcriptomic and single-cell RNA sequencing data, supplemented with in vitro functional validation.
methodsPublicly available meningioma transcriptomic datasets were analyzed to identify differentially expressed cellular senescence-associated genes (CSA-DEGs). Weighted gene co-expression network analysis (WGCNA) was employed to detect key gene modules. Subsequently, machine learning algorithms, including LASSO regression and random forest, were applied to precisely select CSA-signature genes. Immune infiltration analysis combined with single-cell RNA sequencing data was conducted to characterize macrophage subpopulations and the expression patterns of key genes within the meningioma immune microenvironment. Finally, in vitro gene knockdown experiments were performed to validate the functional roles of GAPDH, CCND1, and HBEGF in meningioma and M2 macrophage polarization.
resultsA total of 43 CSA-DEGs were identified, significantly enriched in pathways related to cellular senescence, the p53 signaling pathway, and inflammatory responses. WGCNA revealed 28 key immune regulatory genes. Immune infiltration analysis showed significant enrichment of M2 macrophages and regulatory T cells in meningioma tissues. Single-cell analysis demonstrated heterogeneity in M2 macrophage populations and differential expression of CSA-signature genes. In vitro knockdown of GAPDH and CCND1 markedly suppressed pro-inflammatory factor expression, whereas HBEGF knockdown reduced anti-inflammatory cytokine secretion by M2 macrophages. These three genes appear to synergistically modulate the immune microenvironment in meningioma.
conclusionCellular senescence-associated genes GAPDH, CCND1, and HBEGF show associations with M2 macrophage polarization and inflammatory cytokine secretion in meningioma. These observations suggest their potential involvement in shaping an immunosuppressive tumor microenvironment and warrant further investigation as possible therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.